SEC Form 4 · accession 0001651308-19-000025
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane Huang
Officer — CMO, Hematology
Period of report
Mar 7, 2019
Accepted (ET)
Mar 11, 2019 · 7:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1,F3 | Mar 7, 2019 | S | 71 | $140.501 | D | 0 | D | |
| American Depositary SharesF1,F4 | Mar 11, 2019 | M | 2,565 | $29.49 | A | 2,565 | D | |
| American Depositary SharesF1 | Mar 11, 2019 | S | 2,565 | $130.00 | D | 0 | D | |
| Ordinary Shares | holding | — | — | — | 271,621 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F5,F6 | $2.27 | Mar 11, 2019 | M | 33,345 | A | — | Sep 2, 2026 | Ordinary Shares | 33,345 | 1,295,155 | D |
Explanation of responses
- F1Each American Depositary Share ("ADS") represents 13 Ordinary Shares.
- F2The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F3These shares were acquired under the BeiGene, Ltd. Second Amended and Restated Employee Share Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F4The exercise price is reflected in ADSs.
- F5The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares.
- F6These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events.